Qiagen NV | QIA - 流动资产

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.31B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	流动资产	更改		日
Akebia Therapeutics	USD 229.55M		13.93M	2026-06
Alaunos Therapeutics	USD 970K		1.02M	2026-03
argenx SE	USD 8.07B		1.17B	2026-06
Avita Medical	AUD 35.49M		760K	2025-12
Dianthus Therapeutics	USD 897.54M		222.37M	2026-06
Ionis Pharmaceuticals	USD 2.49B		446.73M	2026-06
IQVIA Holdings	USD 6.23B		6M	2026-06
Moderna	USD 5.82B		45M	2026-06
Organon & Co	USD 5.11B		179M	2026-06
Qiagen NV	USD 1.66B		116.37M	2026-06
Revvity	USD 2.3B		169.4M	2026-06
Tectonic Therapeutic	USD 239.89M		17.47M	2026-03
Viatris	USD 10.06B		861.1M	2026-06
Xeris Pharmaceuticals	USD 274.76M		23.08M	2026-06